Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7058 in Advanced Pancreatic Cancer
NCT07589569Phase 2Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7058 in pancreatic cancer (PC), sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Jun 2026; status: recruiting.
02
Drugs
HRS-7058
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07589569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07589569.